Procter & Gamble Hygiene and Health Care Limited (BOM:500459)
India · Delayed Price · Currency is INR 6,804.20
-102.40 (-1.48%)
At close: Oct 22, 2026
BOM:500459 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 220,869 | 302,696 | 441,580 | 539,512 | 464,331 | 435,092 | |
Market Cap Growth | -50.98% | -31.45% | -18.15% | 16.19% | 6.72% | 0.56% |
Enterprise Value | 215,199 | 294,786 | 433,760 | 532,524 | 454,919 | 425,070 |
Last Close Price | 6804.20 | 9254.96 | 13216.66 | 15924.35 | 13494.39 | 12512.19 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 27.93 | 35.34 | 61.53 | 79.93 | 68.47 | 75.57 |
PS Ratio | 5.20 | 7.06 | 10.26 | 12.83 | 11.85 | 11.15 |
PB Ratio | 29.31 | 40.17 | 59.92 | 69.63 | 49.08 | 58.99 |
P/TBV Ratio | 29.31 | 40.17 | 59.92 | 69.63 | 49.08 | 58.99 |
P/FCF Ratio | 25.26 | 34.61 | 60.98 | 126.84 | 59.43 | 83.14 |
P/OCF Ratio | 23.90 | 32.76 | 55.37 | 114.79 | 56.23 | 75.92 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 5.07 | 6.87 | 10.07 | 12.66 | 11.61 | 10.90 |
EV/EBITDA Ratio | 20.05 | 24.74 | 42.92 | 52.67 | 51.96 | 50.56 |
EV/EBIT Ratio | 20.75 | 25.54 | 44.76 | 55.72 | 55.59 | 53.86 |
EV/FCF Ratio | 24.61 | 33.71 | 59.90 | 125.20 | 58.22 | 81.23 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Debt / FCF Ratio | - | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Net Debt / Equity Ratio | -0.75 | -0.74 | -0.63 | -0.74 | -1.01 | -0.84 |
Net Debt / EBITDA Ratio | -0.53 | -0.47 | -0.46 | -0.56 | -1.10 | -0.74 |
Net Debt / FCF Ratio | - | -0.64 | -0.64 | -1.34 | -1.23 | -1.18 |
Asset Turnover | - | 2.41 | - | 2.11 | 2.05 | 2.35 |
Inventory Turnover | - | 7.14 | - | 7.32 | 7.36 | 6.49 |
Quick Ratio | - | 0.91 | 0.89 | 0.92 | 1.12 | 0.97 |
Current Ratio | - | 1.22 | 1.23 | 1.22 | 1.38 | 1.32 |
Return on Equity (ROE) | - | 114.93% | - | 78.45% | 80.56% | 79.31% |
Return on Assets (ROA) | - | 40.54% | - | 29.89% | 26.78% | 29.76% |
Return on Invested Capital (ROIC) | 398.85% | 360.36% | 299.11% | 721.11% | 1272.22% | 612.55% |
Return on Capital Employed (ROCE) | - | 132.90% | 113.50% | 108.90% | 77.80% | 95.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 3.58% | 2.83% | 1.63% | 1.25% | 1.46% | 1.32% |
FCF Yield | 3.96% | 2.89% | 1.64% | 0.79% | 1.68% | 1.20% |
Dividend Yield | 3.38% | 2.47% | 1.71% | 1.17% | 1.29% | 1.19% |
Payout Ratio | 104.68% | 98.54% | 123.64% | 127.44% | 69.41% | 98.66% |
Buyback Yield / Dilution | -0.00% | 0.00% | -0.00% | - | - | - |
Total Shareholder Return | 3.38% | 2.47% | 1.71% | 1.17% | 1.29% | 1.19% |